Impact of immunopathology on the antituberculous activity of pyrazinamide

In the 1970s, inclusion of pyrazinamide (PZA) in the drug regimen of tuberculosis (TB) patients for the first 2 mo achieved a drastic reduction of therapy duration. Until now, however, the mechanisms underlying PZA’s unique contribution to efficacy have remained controversial, and animal efficacy da...

Descripción completa

Detalles Bibliográficos
Autores principales: Blanc, Landry, Sarathy, Jansy Passiflora, Alvarez Cabrera, Nadine, O’Brien, Paul, Dias-Freedman, Isabela, Mina, Marizel, Sacchettini, James, Savic, Radojka M., Gengenbacher, Martin, Podell, Brendan K., Prideaux, Brendan, Ioerger, Thomas, Dick, Thomas, Dartois, Véronique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080910/
https://www.ncbi.nlm.nih.gov/pubmed/30018074
http://dx.doi.org/10.1084/jem.20180518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080910/
https://www.ncbi.nlm.nih.gov/pubmed/30018074
http://dx.doi.org/10.1084/jem.20180518

Ejemplares similares